Skip to navigation | Skip to main content | Skip to footer

Paterson Institute for Cancer Research

The Paterson Institute is an internationally renowned centre for cancer research which is supported by major core funding from Cancer Research UK in the order of £8.5 million per year. The Paterson Institute is an integral part of the oncology centre at Christie Hospital - a specialist cancer hospital serving the North West of England - and is part of the University of Manchester . It supports a number of investigative programmes, spanning both basic and translational cancer research. It has excellent laboratory facilities and outstanding core services, including microarrays, confocal microscopy, bioinformatics, histology, and access to mass-spectrometry based proteomics.

The Institute comprises over 250 postdoctoral scientists, clinical fellows, scientific officers, administrative and technical staff, postgraduate research students and visiting fellows. It houses both Cancer Research UK core-funded groups and other research activities focusing on cancer, including the Cancer Research UK Department of Medical Oncology Gene Immunotherapy, Glycoangiogenesis, and Proteoglycan Groups, the Cancer Research UK Children's Cancer Group and the University of Manchester Division of Cancer Studies Translational Radiogenomics, Breast Biology and Targeted Therapy Groups. The groups are working on many aspects of cancer research spanning basic biology through to translational and clinical research, and there is considerable synergy and interaction between the groups.